Global Plasma Therapy market will reach 389.7 million US$ by the end of 2025

Publisher: QYResearch
Published Date: 2019/8/20

Plasma therapy uses platelet-rich plasma protein that is extracted from blood to treat the patient. The high incidence of life-altering conditions such as idiopathic thrombocytopenic purpura (ITP), chronic inflammatory demyelinating polyneuropathy (CIPD), and multifocal motor neuropathy (MMN) are expected to boost the global plasma therapy market. Furthermore, the rise of contagious diseases has created a positive impact on the global market for plasma therapy.

Growth of the global plasma therapy market can also be attributed to the rapid pace of technological advancements that brought in affordable protein fractioning technologies from plasma. Supportive government incentives for development of plasma derived medicine, as blood donation drives gain momentum, are expected to favor market growth during the forecast period.

According to the research report, the global plasma therapy market was valued at US$197 mn in 2018 and is expected to reach US$389.7 mn by the end of 2025. During the forecast years of 2019 and 2025, the global market for plasma therapy is projected to register a CAGR of 10.0%.

Click to view the full report:
https://www.qyresearch.com/index/detail/1050563/global-plasma-therapy-market
This article was first released by QYResearch, if reproduced, please indicate the source.
Telephone number:020-86655165
Contact:press@qyresearch.com
When contacting, please refer to QYR company's Mia introduction.